House Committee Report
Underlined text would be added to current law. Struck-through text would be removed.
| By: Hall, et al. | S.B. No. 1986 | |
| (VanDeaver) | ||
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to warning labels for opioid prescription drugs. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 481.074(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) A pharmacist may not: | |
| (1) dispense or deliver a controlled substance or | |
| cause a controlled substance to be dispensed or delivered under the | |
| pharmacist's direction or supervision except under a valid | |
| prescription and in the course of professional practice; | |
| (2) dispense a controlled substance if the pharmacist | |
| knows or should have known that the prescription was issued without | |
| a valid patient-practitioner relationship; | |
| (3) fill a prescription that is not prepared or issued | |
| as prescribed by this chapter; | |
| (4) permit or allow a person who is not a licensed | |
| pharmacist or pharmacist intern to dispense, distribute, or in any | |
| other manner deliver a controlled substance even if under the | |
| supervision of a pharmacist, except that after the pharmacist or | |
| pharmacist intern has fulfilled his professional and legal | |
| responsibilities, a nonpharmacist may complete the actual cash or | |
| credit transaction and delivery; [ |
|
| (5) permit the delivery of a controlled substance to | |
| any person not known to the pharmacist, the pharmacist intern, or | |
| the person authorized by the pharmacist to deliver the controlled | |
| substance without first requiring identification of the person | |
| taking possession of the controlled substance, except as provided | |
| by Subsection (n); or | |
| (6) dispense an opioid unless the bottle or container | |
| in which the opioid is dispensed is affixed with a label warning of | |
| the addictive nature of opioids and the risks of respiratory | |
| depression and overdose as required by board rule under Section | |
| 481.0761(l). | |
| SECTION 2. Section 481.0761, Health and Safety Code, is | |
| amended by adding Subsection (l) to read as follows: | |
| (l) The board shall adopt rules requiring that an opioid be | |
| dispensed in a bottle or container affixed with a label warning | |
| users of the addictive nature of opioids and the risks of | |
| respiratory depression and overdose. The label must include | |
| language substantially similar to the following: | |
| "CAUTION: Opioid. Risk of Addiction, Respiratory Depression, | |
| and Overdose.". | |
| SECTION 3. The Texas State Board of Pharmacy shall adopt the | |
| rules required under Section 481.0761(l), Health and Safety Code, | |
| as added by this Act, not later than January 1, 2026. | |
| SECTION 4. The change in law made by this Act applies only | |
| to a prescription for an opioid dispensed on or after March 1, 2026. | |
| A prescription dispensed before March 1, 2026, is governed by the | |
| law in effect immediately before the effective date of this Act, and | |
| the former law is continued in effect for that purpose. | |
| SECTION 5. This Act takes effect immediately if it receives | |
| a vote of two-thirds of all the members elected to each house, as | |
| provided by Section 39, Article III, Texas Constitution. If this | |
| Act does not receive the vote necessary for immediate effect, this | |
| Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.